HENZO KENYA is a registered Community-Based Organization (CBO) dedicated to supporting individuals affected by cancer and rare diseases. We focus on public awareness, mutual support, advocacy, and research to improve outcomes for patients across Kenya.

Our primary mission is to reduce mortality from Leukemia (CML, AML, ALL, MPN, Lymphomas), Gastrointestinal Stromal Tumors (GIST), and other related conditions.

A community of about 2000, and growing, from all over the country, who are brought together by a medicine called Glivec (Imatinib) made by Novartis from Switzerland